Acorah Software Products - Accounts Production 16.8.200 false true 31 March 2024 1 April 2023 false true No description of principal activity 1 April 2024 31 March 2025 31 March 2025 10179346 Mr Amrik Gill iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10179346 2024-03-31 10179346 2025-03-31 10179346 2024-04-01 2025-03-31 10179346 frs-core:CurrentFinancialInstruments 2025-03-31 10179346 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10179346 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 10179346 frs-bus:Micro-entities 2024-04-01 2025-03-31 10179346 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10179346 frs-bus:Director1 2024-04-01 2025-03-31 10179346 2023-03-31 10179346 2024-03-31 10179346 2023-04-01 2024-03-31 10179346 frs-core:CurrentFinancialInstruments 2024-03-31
Registered number: 10179346
ASG PHARMA LTD
Financial Statements
For The Year Ended 31 March 2025
Balance Sheet
Registered number: 10179346
2025 2024
£ £
Current assets 62,124 65,815
Creditors: Amounts Falling Due Within One Year (133 ) (3,083 )
NET CURRENT ASSETS 61,991 62,732
TOTAL ASSETS LESS CURRENT LIABILITIES 61,991 62,732
Accruals and deferred income (650 ) (750 )
NET ASSETS 61,341 61,982
CAPITAL AND RESERVES 61,341 61,982

Notes

1. General Information
ASG PHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 10179346 . The registered office is 64 VICTORIA PARK ROAD, SMETHWICK, WEST MIDLANDS, B66 3QL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
Page 0
Page 1
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Amrik Gill
Director
29/12/2025